Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00APD
|
||||
Former ID |
DNC005854
|
||||
Drug Name |
3-(2-Dimethylamino-ethyl)-1H-indol-6-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527668] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H16N2O
|
||||
Canonical SMILES |
CN(C)CCC1=CNC2=C1C=CC(=C2)O
|
||||
InChI |
1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-7-10(15)3-4-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3
|
||||
InChIKey |
WUQMRWPLIMXBDX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527668] | |
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527668] | ||
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527668] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.